Sept. 17, 2021

A Promising Repurpose: Tenax Therapeutics Tests the Cancer Drug Imatinib in Pulmonary Arterial Hypertension

A Promising Repurpose: Tenax Therapeutics Tests the Cancer Drug Imatinib in Pulmonary Arterial Hypertension

Christopher Giordano, MS, explains how an American English major studying at Oxford University lucked into marrying a Welsh girl he convinced to move to North Carolina’s Research Triangle – a hotbed of literary studies. From that beginning – somehow – Giordano got a "real job" in drug development, rising through the ranks to become president of a business unit in healthcare giant, IQVIA, and eventually, CEO of Tenax. He tells me the Tenax name comes from the word "tenacity". Of this, I have no doubt. Now listen to him spin imatinib into gold for Pulmonary Arterial Hypertension (PAH).